ALNYLAM PHARMACEUTICALS, INC.·4

May 12, 4:07 PM ET

BONNEY MICHAEL W 4

4 · ALNYLAM PHARMACEUTICALS, INC. · Filed May 12, 2025

Insider Transaction Report

Form 4
Period: 2025-05-08
Transactions
  • Award

    Stock Option (right to buy)

    2025-05-08+1,5581,558 total
    Exercise: $258.35From: 2026-05-08Exp: 2035-05-08Common Stock (1,558 underlying)
  • Award

    Common Stock

    2025-05-08+77516,804 total
Holdings
  • Common Stock

    (indirect: By Trust)
    4,000
Footnotes (3)
  • [F1]These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.
  • [F2]The shares of ALNY common stock were purchased by the Michael W. Bonney Revocable Trust, of which the reporting person is trustee.
  • [F3]The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT